Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Liver International : Official Journal of the International Association for the Study of the Liver|August 21, 2024
Lymphotoxin beta-activated LTBR/NIK/RELB axis drives proliferation in cholangiocarcinomaKaiyu Xu, Annika Kessler, Federico Nichetti, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 2, 2017
Molecular testing for the clinical diagnosis of fibrolamellar carcinomaRondell P Graham, Matthew M Yeh, Dora Lam-Himlin, et al.
Cancer Discovery|July 20, 2021
Genetic Screens Identify a Context-Specific PI3K/p27Kip1 Node Driving Extrahepatic Biliary CancerChiara Falcomatà, Stefanie Bärthel, Angelika Ulrich, et al.
Annals of Surgical Oncology|June 19, 2024
Comparing Survival of Perihilar Cholangiocarcinoma After R1 Resection Versus Palliative Chemotherapy for Unresected Localized DiseaseAnne-Marleen van Keulen, Stefan Buettner, Pim B Olthof, et al.
Hepatology (Baltimore, Md.)|January 12, 2020
Genomic Characterization of Cholangiocarcinoma in Primary Sclerosing Cholangitis Reveals Therapeutic OpportunitiesBenjamin Goeppert, Trine Folseraas, Stephanie Roessler, et al.
Journal of Hepatology|May 16, 2021
Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitisRoser Pinyol, Sara Torrecilla, Huan Wang, et al.
Nature Reviews. Gastroenterology & Hepatology|February 9, 2023
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevanceDiego F Calvisi, Luke Boulter, Javier Vaquero, et al.
Clinical and Translational Medicine|June 15, 2024
Integrative genomic analyses of European intrahepatic cholangiocarcinoma: Novel ROS1 fusion gene and PBX1 as prognostic markerPatrick S Plum, Timo Hess, Denis Bertrand, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 19, 2022
Bcl-xL as prognostic marker and potential therapeutic target in cholangiocarcinomaPaula Hoffmeister-Wittmann, Andreas Mock, Federico Nichetti, et al.
Hepatology (Baltimore, Md.)|November 2, 2023
Etiology-independent activation of the LTβ-LTβR-RELB axis drives aggressiveness and predicts poor prognosis in HCCAnna-Lena Scherr, Luisa Nader, Kaiyu Xu, et al.
Pageof 12